We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
151
D.R. Horton
DHI
$41.2B
$511K 0.15%
7,413
+7,387
+28,412% +$539K
SMPL icon
152
Simply Good Foods
SMPL
$907M
$508K 0.15%
+16,204
New +$377K
TPIC
153
DELISTED
TPI Composites
TPIC
$503K 0.15%
9,533
+8,628
+953% +$345K
KURE icon
154
KraneShares MSCI All China Health Care Index ETF
KURE
$98.7M
$501K 0.15%
+12,819
New +$453K
CONE
155
DELISTED
CyrusOne Inc Common Stock
CONE
$499K 0.15%
6,825
-2,424
-26% -$176K
CELH icon
156
Celsius Holdings
CELH
$7.38B
$498K 0.15%
+29,682
New +$296K
FTCH
157
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$492K 0.14%
7,706
+906
+13% +$40.1K
ABBV icon
158
AbbVie
ABBV
$465B
$489K 0.14%
4,567
-6,329
-58% -$608K
KLAC icon
159
KLA
KLAC
$222B
$489K 0.14%
18,880
-2,580
-12% -$60.1K
DVA icon
160
DaVita
DVA
$15.5B
$488K 0.14%
4,161
-1,594
-28% -$162K
CPRT icon
161
Copart
CPRT
$28.5B
$488K 0.14%
15,336
+15,308
+54,671% +$446K
JOUT icon
162
Johnson Outdoors
JOUT
$496M
$488K 0.14%
+4,330
New +$394K
AOS icon
163
A.O. Smith
AOS
$8.55B
$487K 0.14%
+8,893
New +$490K
TME icon
164
Tencent Music
TME
$15.9B
$487K 0.14%
25,330
-8,987
-26% -$146K
AAPL icon
165
Apple
AAPL
$4.97T
$486K 0.14%
+3,661
New +$440K
EDU icon
166
New Oriental
EDU
$9.32B
$483K 0.14%
2,600
+2,562
+6,742% +$431K
ORCL icon
167
Oracle
ORCL
$339B
$482K 0.14%
7,458
+7,423
+21,209% +$442K
CPB icon
168
Campbell Soup
CPB
$6.85B
$476K 0.14%
9,848
-689
-7% -$33.3K
ISRG icon
169
Intuitive Surgical
ISRG
$127B
$476K 0.14%
1,746
-249
-12% -$61.8K
LIT icon
170
Global X Lithium & Battery Tech ETF
LIT
$1.46B
$475K 0.14%
7,669
TRP icon
171
TC Energy
TRP
$70.1B
$470K 0.14%
11,568
-150
-1% -$6.39K
NVCR icon
172
NovoCure
NVCR
$1.77B
$469K 0.14%
+2,709
New +$371K
WMT icon
173
Walmart Inc
WMT
$909B
$467K 0.14%
+9,729
New +$472K
TRUP icon
174
Trupanion
TRUP
$1.13B
$463K 0.14%
+3,866
New +$365K
ADM icon
175
Archer Daniels Midland
ADM
$38.7B
$462K 0.14%
9,161
-2,553
-22% -$126K

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.